i3S - Institute for Research and Innovation in Health

i3S is a Research Institute resulting from a consortium between IBMC, INEB, IPATIMUP and UPORTO, that creates an environment of real breakthrough research and translation of discoveries into the clinic. i3S was rated “Excellent” (2025) by the Portuguese Foundation for Science and Technology (FCT), and is dedicated to research and innovation in basic, applied and translational Health and Life sciences. It focuses on 3 research programs addressing major challenges as cancer, infectious diseases, neurologic disorders and regenerative medicine. i3S has 65 research groups with 432 PhDs and 275 PhD students, publishes around 700 papers a year, and has 3 Clinical and Diagnostic platforms that provide clinical services to the community. Also, i3S has 31 active patents (6 internationalized in 2025), 9 spin-offs, developed 27 licensing agreements, 30 R&D contracted projects, launched 2 rounds of an acceleration program, organized 3 editions of a health innovation award, and brought 5 products to the market. i3S fosters continuous advanced trainings for scientists and implements annual educational and outreach activities to close the gap between science and society. i3S adopted the HRS4R Strategy in 2021 and is a member of the Coalition for Advancing Research Assessment.